Another promising cancer treatment rolls off the line at UCSD.
Nanoparticles are the new medical wonder gadget. Journals
are filled with new and interesting uses for microscopic particles of different
makes and models being used for treatments of anything from cancer
to radiation poisoning. The carbon nanotube seems to be the most popular
delivery method for various treatments due to several factors like their ease
of production and chemical inertness.
Some worry that these nanoparticles aren't safe over long periods of time, however.
Nanotubes of certain lengths have been shown to produce results similar to
those of a known carcinogen, asbestos.
Other studies revolve around the tiny spears and their effects on the liver or
kidneys.
University of California at San Diego researchers recently published work which
uses nanoparticles to deliver chemical toxins to specific cancer cells in mice.
This is not a very new development, DailyTech readers have read about
several such endeavors in the past. However, UCSD's delivery method and drug
approach are a little
different.
First, the UCSD nanoparticles are not carbon nanotubes. Their nanoparticles are
composed of lipid-based polymers instead. Second, instead of using various
means of energy or activation on their nanoparticles, UCSD's are a more
traditional search and destroy variety. The particles are programmed to seek
out a specific protein marker called integrin ανβ3. Rather than relying on
detonating a payload onsite, the particles deliver a widely used chemotherapy
toxin called doxorubicin directly to the tumors, effectively killing tumor
cells while leaving healthy cells in the area largely unaffected.
David Cheresh, Ph.D, the Moores UCSD Cancer Center Director of Translational
Research, explains “doxorubicin is known to be an effective anti-cancer drug,
but has been difficult to give patients an adequate dose without negative side
effects. This new strategy represents the first time we’ve seen such an impact
on metastatic growth, and it was accomplished without the collateral damage of
weight loss or other outward signs of toxicity in the patient.”
While the treatment was found to have little effect on primary tumors, it
effectively prevented metastasizing in pancreatic and kidney cancers of mice.
Metastasis is typically more difficult to treat than primary tumors, and is
often the cause of death in cancer victims. Integrin ανβ3 is expressed by
tumorous blood vessels that give rise to angiogenesis, or the formation of new
blood vessels. Metastasis is more reliant on new vessel growth than established
tumors, so targeting these areas with chemotherapy may help to prevent it.
"You can bet that Sony built a long-term business plan about being successful in Japan and that business plan is crumbling." -- Peter Moore, 24 hours before his Microsoft resignation
|
Most Popular ArticlesGoogle's IPhone App Sets Trend Rebelling Against Apple's Rules November 27, 2008, 9:04 PM The Same Chip With Fewer Transistors; HP's Memristor Changes Everything November 26, 2008, 11:23 AM Tom's Holiday Gift Guide November 28, 2008, 2:21 PM Xbox 360 Jasper Revision Available Now November 28, 2008, 10:22 AM Apple Slashes MacBook Price to $899 for Black Friday November 26, 2008, 11:06 AM
|